Skip to Content

American Bio Medica Corp ABMC

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ABMC is trading at a 58% discount.
Price
$0.00
Fair Value
$5.38
Uncertainty
Extreme
1-Star Price
$1.98
5-Star Price
$5.49
Economic Moat
Kjhkc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ABMC is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.02
Bid/Ask
$0.00 / $0.01
Market Cap
$14,429.54
Volume/Avg
2,570 / 6,077

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

American Bio Medica Corp is a us-based company engaged in manufacturing and selling lateral flow immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids at the point of collection. It also manufactures and sells drug testing products and provides bulk test strip manufacturing services to unaffiliated third parties on a contract basis. The company offers few urine tests which include Rapid Drug Screen, RDS InCup, Rapid TOX, and Rapid TOX Cup II. Its target customer includes workplace, government, corrections, clinical and educational markets. Geographically, it derives a majority of revenue from the United States.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Value
Total Number of Employees
24

Valuation

Metric
ABMC
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ABMC
Quick Ratio
0.32
Current Ratio
0.59
Interest Coverage
6.08
Quick Ratio
ABMC

Profitability

Metric
ABMC
Return on Assets (Normalized)
−183.76%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
ABMC
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncXpbxzcmbzSnjkl$206.7 Bil
DHR
Danaher CorpLrtqzxqlbCbfrybw$175.0 Bil
IQV
IQVIA Holdings IncZshtwhryvZpmgtp$41.3 Bil
IDXX
IDEXX Laboratories IncGbdvzlwrjmCblhw$39.7 Bil
A
Agilent Technologies IncMxfrgfzpgyYth$38.8 Bil
MTD
Mettler-Toledo International IncTrqcycpcwKvrbsyl$25.5 Bil
ICLR
Icon PLCMpnnwgrqKjtsm$24.1 Bil
ILMN
Illumina IncRcqssfpgrLcdxmq$18.6 Bil
WAT
Waters CorpKwxzgbmcTlb$18.0 Bil
LH
Laboratory Corp of America HoldingsBgdkhrwcxRjbdw$16.8 Bil

Sponsor Center